Literature DB >> 8619525

Hypersomnia following paramedian thalamic stroke: a report of 12 patients.

C Bassetti1, J Mathis, M Gugger, K O Lovblad, C W Hess.   

Abstract

Paramedian thalamic stroke (PTS) is a cause of organic hypersomnia, which in the absence of systematic sleep-wake studies has been attributed to disruption of ascending activating impulses and considered a "dearoused" state. However, an increasing mount of data suggests a role of the thalamus in sleep regulation and raises the possibility that a sleep disturbance contributes to hypersomnia in PTS. We evaluated 12 patients with magnetic resonance imaging-proven isolated PTS and hypersomnia with 10 to >20 hours of sleep behavior per day. Nocturnal polysomnographic findings paralleled the severity of hypersomnia. All subjects had increased stage 1 NREM sleep, reduced stage 2 NREM sleep, and reduced numbers of sleep spindles. In patients with severe hypersomnia, slow-wave (stages 3-4) NREM sleep was often reduced, but there were no major REM sleep alterations. Daytime sleep behavior was associated mostly with stage 1 sleep by electroencephalogram; there was no correlation between hypersomnia and results of nap tests. We conclude that hypersomnia following PTS is accompanied by deficient arousal during the day and insufficient spindling and slow-wave sleep production at night. These observations support the hypothesis of a dual role of the paramedian thalamus as "final common pathway' for both maintenance of wakefulness and promotion of NREM sleep.

Entities:  

Mesh:

Year:  1996        PMID: 8619525     DOI: 10.1002/ana.410390409

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  39 in total

1.  Magnetic resonance spectroscopy in a patient with Kleine-Levin syndrome.

Authors:  R Poryazova; B Schnepf; P Boesiger; C L Bassetti
Journal:  J Neurol       Date:  2007-10-15       Impact factor: 4.849

2.  [Fatal familial insomnia: case presentation and discussion of typical clinical and imaging findings].

Authors:  A V Thomas; J C Klein; A Brockhaus-Dumke; W D Heiss; A H Jacobs; H F Petereit
Journal:  Nervenarzt       Date:  2006-06       Impact factor: 1.214

3.  Frequency-selective control of cortical and subcortical networks by central thalamus.

Authors:  Jia Liu; Hyun Joo Lee; Andrew J Weitz; Zhongnan Fang; Peter Lin; ManKin Choy; Robert Fisher; Vadim Pinskiy; Alexander Tolpygo; Partha Mitra; Nicholas Schiff; Jin Hyung Lee
Journal:  Elife       Date:  2015-12-10       Impact factor: 8.140

Review 4.  Sleep and neurological diseases.

Authors:  A Autret
Journal:  J Neurol       Date:  1997-04       Impact factor: 4.849

5.  Sleep Apnea and Other Sleep-Wake Disorders in Stroke.

Authors:  Dirk M. Hermann; Claudio L. Bassetti
Journal:  Curr Treat Options Neurol       Date:  2003-05       Impact factor: 3.598

6.  Global enhancement of cortical excitability following coactivation of large neuronal populations.

Authors:  Deng Zhang; Xingjian Yan; Liang She; Yunqing Wen; Mu-Ming Poo
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-03       Impact factor: 11.205

7.  Post-stroke apathy and hypersomnia lead to worse outcomes from acute rehabilitation.

Authors:  Ari L Harris; Jessica Elder; Nicholas D Schiff; Jonathan D Victor; Andrew M Goldfine
Journal:  Transl Stroke Res       Date:  2013-10-19       Impact factor: 6.829

Review 8.  Excessive daytime sleepiness and sleep disturbances in patients with neurological diseases: epidemiology and management.

Authors:  Svenja Happe
Journal:  Drugs       Date:  2003       Impact factor: 9.546

9.  Excessive Daytime Sleepiness in Acute Ischemic Stroke: Association With Restless Legs Syndrome, Diabetes Mellitus, Obesity, and Sleep-Disordered Breathing.

Authors:  Pavel Šiarnik; Katarína Klobučníková; Pavol Šurda; Matúš Putala; Stanislav Šutovský; Branislav Kollár; Peter Turčáni
Journal:  J Clin Sleep Med       Date:  2018-01-15       Impact factor: 4.062

10.  Why we sleep: the temporal organization of recovery.

Authors:  Emmanuel Mignot
Journal:  PLoS Biol       Date:  2008-04-29       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.